Inspection Record

12719924 Canada Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2021-04-08 3 findingsOther quality systemMaterial and supplier controlStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.

2Material and supplier control

The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.

3Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-04-08. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

12719924 Canada Ltd. company profile — full history Health Canada documents, 2021 Go to Findings search